Safety of Baricitinib in Japanese Patients with Rheumatoid Arthritis (RA): The 2020 Interim Report from All-case Post Marketing Surveillance in Clinical Practice

被引：0
|
作者：
Fujii, Takao [1 ]
Atsumi, Tatsuya [2 ]
Okamoto, Nami [3 ]
Takahashi, Nobunori [4 ]
Tamura, Naoto [5 ]
Nakajima, Atsuo [6 ]
Nakajima, Ayako [7 ]
Matsuno, Hiroaki [8 ]
Tsujimoto, Naoto [9 ]
Nishikawa, Atsushi [9 ]
Ishii, Taeko [9 ]
Takeuchi, Tsutomu [10 ]
Kuwana, Masataka [11 ]
Takagi, Michiaki [12 ]
机构：
[1] Wakayama Med Univ, Dept Rheumatol & Clin Immunol, Wakayama, Japan
[2] Hokkaido Univ, Sapporo, Hokkaido, Japan
[3] Osaka Med Coll, Takatsuki, Osaka, Japan
[4] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan
[5] Juntendo Univ, Fac Med, Dept Internal Med & Rheumatol, Tokyo, Japan
[6] Ueno Touseki Clin, Fukuoka, Japan
[7] Mie Univ Hosp, Ctr Rheumat Dis, Tsu, Mie, Japan
[8] Matsuno Clin Rheumat Dis, Toyama, Japan
[9] Eli Lilly Japan KK, Kobe, Hyogo, Japan
[10] Keio Univ, Div Rheumatol, Tokyo, Japan
[11] Nippon Med Sch, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan
[12] Yamagata Univ, Fac Med, Dept Orthopaed Surg, Yamagata, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1676
引用
收藏
页码：3489 / 3490
页数：2
相关论文
共 50 条
  • [21] Drug use investigation on the safety and efficacy of tigecycline in Japan (all-case post-marketing surveillance)
    Ohashi, Takahisa
    Sugiyama, Noriko
    Watanabe, Toshiya
    Uryu, Taku
    Yoshinaga, Yukari
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (07) : 866 - 874
  • [22] Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis
    Takeuchi, Tsutomu
    Kawai, Shinichi
    Yamamoto, Kazuhiko
    Harigai, Masayoshi
    Ishida, Kota
    Miyasaka, Nobuyuki
    MODERN RHEUMATOLOGY, 2014, 24 (01) : 8 - 16
  • [23] Safety of infliximab therapy in 4,475 Japanese patients with rheumatoid arthritis: Results from post marketing surveillance study
    Takeuchi, T.
    Togo, M.
    Etoh, A.
    Suzuki, T.
    Callegari, P. A.
    Gilmer, K. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 503 - 504
  • [24] Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance
    Harigai, Masayoshi
    Ishiguro, Naoki
    Inokuma, Shigeko
    Mimori, Tsuneyo
    Ryu, Junnosuke
    Takei, Syuji
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Takasaki, Yoshinari
    Yamanaka, Hisashi
    Yoshizawa, Yuri
    Chineni, Ichino
    Nakao, Toru
    Koike, Takao
    MODERN RHEUMATOLOGY, 2019, 29 (05) : 747 - 755
  • [25] A JAPANESE POST-MARKETING SURVEILLANCE OF REGORAFENIB IN COLORECTAL CANCER PATIENTS: INTERIM REPORT
    Satoh, Taroh
    Yamazaki, Naoya
    Takikawa, Hajime
    Ito, Hideyuki
    Ito, Yuichiro
    Sakaguchi, Toshiaki
    Yamada, Takashi
    Muro, Kei
    Sugihara, Kenichi
    ANNALS OF ONCOLOGY, 2014, 25
  • [26] Interim Results of Natalizumab Therapy in Patients with Multiple Sclerosis from The All-Case Surveillance in Japan
    Saida, Takahiko
    Sato, Ryusuke
    Hase, Masakazu
    Ling, Yan
    Torii, Shinichi
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 337 - 337
  • [27] Real-world safety of nivolumab in patients with non-small cell lung cancer (NSCLC) in Japan: Interim summary of post-marketing all-case surveillance
    Ohe, Y.
    Gemma, A.
    Nakagawa, K.
    Yamamoto, N.
    Saito, T.
    Akamatsu, A.
    Kuwano, K.
    Nakanishi, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [28] Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry
    Takahashi, Nobunori
    Asai, Shuji
    Kobayakawa, Tomonori
    Kaneko, Atsushi
    Watanabe, Tatsuo
    Kato, Takefumi
    Nishiume, Tsuyoshi
    Ishikawa, Hisato
    Yoshioka, Yutaka
    Kanayama, Yasuhide
    Watanabe, Tsuyoshi
    Hirano, Yuji
    Hanabayashi, Masahiro
    Yabe, Yuichiro
    Yokota, Yutaka
    Suzuki, Mochihito
    Sobue, Yasumori
    Terabe, Kenya
    Ishiguro, Naoki
    Kojima, Toshihisa
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [29] Clinical effectiveness, tuberculosis, and serious infusion reactions in Japanese patients with rheumatoid arthritis: Results from the post marketing surveillance trial
    Dabbous, O.
    Tatsuki, Y.
    Arjunji, R.
    Gilmer, K.
    Rahman, M.
    Togo, M.
    Suzuki, T.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 185 - 185
  • [30] Safety and Effectiveness of Apixaban in Japanese Patients With Venous Thromboembolism in Clinical Practice ― A Post-Marketing Surveillance ―
    Yamada, Norikazu
    Mo, Makoto
    Ohsawa, Ako
    Sato, Motoki
    Umeyama, Michiaki
    Shima, Daisuke
    Nakamura, Mashio
    CIRCULATION JOURNAL, 2024, 88 (02) : 263
12345